Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway
Used in this study: Immunodeficient B-NDG Mice
Read entire articleUsed in this study: Immunodeficient B-NDG Mice
Read entire article